摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Fluoro-4-(5-isobutoxy-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonamide

中文名称
——
中文别名
——
英文名称
2-Fluoro-4-(5-isobutoxy-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonamide
英文别名
2-Fluoro-4-[5-(2-methylpropoxy)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
2-Fluoro-4-(5-isobutoxy-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonamide化学式
CAS
——
化学式
C14H15F4N3O3S
mdl
——
分子量
381.351
InChiKey
HKZIXXOLKISKRJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    95.6
  • 氢给体数:
    1
  • 氢受体数:
    9

文献信息

  • Pyrazole ether derivatives as anti-inflammatory/analgesic agents
    申请人:——
    公开号:US20020058681A1
    公开(公告)日:2002-05-16
    The present invention relates to compounds of the formula 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , A, X and Y are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
    本发明涉及公式1中的化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、A、X和Y的定义如规范中所述,以及含有它们的药物组合物和它们的药用。本发明的化合物在治疗或缓解炎症和其他与炎症相关的疾病方面具有用处,如关节炎、结肠癌和阿尔茨海默病等哺乳动物,最好是人类、狗、猫和家畜动物。
  • PYRAZOLE ETHER DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS
    申请人:Pfizer Products Inc.
    公开号:EP1259504A1
    公开(公告)日:2002-11-27
  • US6878726B2
    申请人:——
    公开号:US6878726B2
    公开(公告)日:2005-04-12
  • [EN] PYRAZOLE ETHER DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS<br/>[FR] DERIVES D'ETHER DE PYRAZOLE UTILISES COMME AGENTS ANTI-INFLAMMATOIRES/ANALGESIQUES
    申请人:PFIZER PROD INC
    公开号:WO2001064669A1
    公开(公告)日:2001-09-07
    The present invention relates to compounds of formula (I), wherein R?1, R2, R3, R4, R5, R6, R7, R8¿, A, X and Y are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
查看更多